Clorox (CLX) PT Lowered to $110 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CLX Hot Sheet
Price: $90.60 -5.43%
Rating Summary:
2 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
2 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst Dara Mohsenian lowered the price target on Clorox (NYSE: CLX) to $110.00 (from $136.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
- Regenxbio Inc. (RGNX) PT Raised to $18 at Leerink
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
